Links to stories about and by members of the Djavad Mowafaghian Centre for Brain Health from February/March 2017.
- News & Events
For media enquiries or more information about research at the Djavad Mowafaghian Centre for Brain Health, please contact Emily Wight, Communications Manager.
“Right now, there is exciting and growing evidence to suggest that the microbiota are associated with some diseases of the brain. However, more work is still needed.” says Dr. Tremlett. “One real challenge will be to prove a causative link.”
A growing field of research is examining the brain patterns produced by people with severe brain injuries who can no longer communicate and appear to be in a vegetative state. Some have argued that one day we may be able to unlock a code from these patterns and communicate with these patients.
According to new research from Dr. Jacqueline Quandt, published recently in Brain, Behaviour and Immunity, a simple compound shows promise in altering immune responses without eliminating cells and in doing so protects the cells in the nervous system and prevents the underlying neurodegeneration in models of MS.
The conclusions about so-called “liberation therapy,” which thousands of people with MS have undergone since 2009, represent the most definitive debunking of the claim that MS patients could achieve dramatic improvements from a one-time medical procedure.
The Alzheimer Society of B.C. and UBC celebrated a decade-long partnership in maintaining the Ralph Fisher and Alzheimer Society of B.C. Professorship in Alzheimer Disease Research earlier this week and welcomed Dr. Robin Hsiung, who was recently awarded the Professorship.
New research from CURE-funded researcher Dr. Stuart Cain, in the laboratory of Dr. Terry Snutch shows that an approved epilepsy drug may be effective in treating migraine in mice.
In recognition of the challenges faced by British Columbians with Parkinson’s disease, the Ministry of Health will be working with the Pacific Parkinson’s Research Centre to identify and prioritize patients for coverage of the medication Duodopa.